I've been thinking about this for a while. We routinely give posterior precautions after posterior approach THA, but the evidence that they actually reduce dislocation risk is pretty thin. Deckard et al. published a series of 580 hips using a monoblock dual mobility construct via mini-posterior approach where they deliberately abandoned traditional posterior precautions. Cup positioning was based on anatomic landmarks rather than radiographic targets. The dislocation rate was 0.2% — a single case, in a patient with pre-existing spinal cord injury and Charcot arthropathy. That aligns well with Clair et al.'s systematic review comparing dislocation rates by approach with dual mobility. Regardless of approach, 80 to 100 percent of studies reported zero postoperative dislocations. And the older but heavily cited review by Petrie and Sassoon noted that restrictive postoperative precautions simply don't influence dislocation rates — whereas lumbosacral pathology, BMI over 30, and surgeon experience do. My read: precautions probably serve no function when you're using dual mobility, and they're unnecessarily limiting early rehabilitation. What's your experience? Have you moved away from them, or are you still giving standard precautions?

Advanced Techniques in Total Knee Arthroplasty Outcomes and Complications 2026Total knee arthroplasty remains one of the most successful orthopedic procedures with over 800000 surgeries performed annually in the United States alone. Understanding the latest outcomes data and complication prevention strategies is essential for improving patient care and surgical success rates. Recent clinical studies from 2026 demonstrate significant improvements in implant longevity with modern cemented and cementless fixation techniques. The 20-year survival rate for primary total knee arthroplasty has reached 95 percent in high-volume centers using evidence-based protocols. Key Advances in Surgical Technique Robotic-assisted total knee arthroplasty has shown superior accuracy in component alignment with deviation rates reduced to less than 2 degrees from planned positioning. This precision translates to improved functional outcomes and reduced revision rates compared to conventional instrumentation. Patient-specific instrumentation continues to evolve with 3D printed cutting guides demonstrating comparable accuracy while reducing operative time by 15 to 20 minutes on average. Complication Management Strategies Periprosthetic joint infection remains the leading cause for revision surgery accounting for 25 percent of all revision procedures. Implementation of comprehensive infection prevention protocols including intranasal mupirocin screening and optimization of perioperative glycemic control has reduced infection rates to below 1 percent in many institutions. Aseptic loosening and polyethylene wear have decreased significantly with highly crosslinked polyethylene showing wear rates less than 0.05mm per year in long-term follow-up studies extending beyond 15 years. Patient Selection and Optimization Preoperative optimization programs addressing modifiable risk factors including obesity body mass index above 40 smoking cessation and nutritional status have demonstrated reduced complication rates by up to 40 percent in high-risk patient populations.

🔧 **2025 REVISION TKA UPDATE: Failure Analysis & Surgical Solutions** Comprehensive review of revision total knee arthroplasty with 2025 evidence 📊 **KEY 2025 EVIDENCE:**[web:284][web:285] • Most common etiologies for revision TKA: Infection (32-39%), instability (15-20%), and aseptic loosening (10-15%) • Early revision rates (< 2 years): TKA 1.3-1.9% vs THA 1.6-2.1% • 2-year revision risk 3x higher than 2-10 year period - critical window • Outpatient revision TKA shows lower readmission & re-revision rates than inpatient[web:288] • Register data from 1.2M+ procedures demonstrates improving revision rates **🦠 ETIOLOGY OF FAILURE (Priority Order):** 1️⃣ **Infection (Most Common Early Failure)** • 32-39% of all revision TKA • Peak risk in first 3 months • Persistent #1 cause regardless of follow-up length • Diagnosis: Synovial WBC >3,000 or PMN% >80% • Treatment: 2-stage revision gold standard 2️⃣ **Instability (15-20%)** • Flexion/extension gap imbalance • Component malrotation • Inadequate soft tissue management • More common in complex primary cases 3️⃣ **Aseptic Loosening (10-15%)** • Decreasing incidence with modern implants • Polyethylene wear remains concern in older implants • Highly cross-linked poly reduces risk by 90% 4️⃣ **Stiffness (8-10%)** • Arthrofibrosis requiring manipulation under anesthesia • Revision indicated if ROM <90° despite rehab 5️⃣ **Patellar Complications (5-8%)** • Maltracking, instability, component loosening • Revised understanding of patella resurfacing benefits **📈 2025 OUTCOME DATA:**[web:285] ✓ **Survival Rates:** • 5-year implant survival: 92-95% • 10-year survival: 85-90% • Infection revisions: Lower survival (75-85% at 5 years) ✓ **Functional Outcomes:** • 70-80% achieve good/excellent KSS • Mean ROM 0-95°(lower than primary) • 15-20% persistent pain despite successful revision ✓ **Complications:** • Re-revision rate: 8-12% at 5 years • Infection: 5-8% (highest risk early postop)

🦠 **2025 ADVANCES: Periprosthetic Joint Infection** Latest diagnostic breakthroughs, treatment innovations, and surgical video demonstrations 📊 **KEY 2025 PJI ADVANCES:**[web:223] **Clinical Challenge:** • Most severe complication after joint arthroplasty • Significant patient morbidity • High healthcare costs • High failure rates with conventional treatments • Growing burden due to increasing TJA demand[web:229] **Pathogen Profile 2025:**[web:226] • Gram-positive bacteria predominant • High methicillin resistance rates • Multidrug resistance increasing • Culture-negative PJI common challenge **🔬 ANTIBIOTIC THERAPY 2025:**[web:223][web:226] **Empirical Treatment Strategies:** 1. **Early Postoperative PJI:** • Broad-spectrum β-lactam + Gram-positive coverage • Immediate surgical debridement • Mixed infections common 2. **Culture-Negative Chronic PJI:** • Preferred: Vancomycin + Meropenem • Alternative: Linezolid + Meropenem • High empirical success rates[web:226] 3. **Culture-Negative Acute Post-Op:** • Suggested: Vancomycin + Ceftazidime • Region-specific protocols important **Targeted Therapy:** • Rifampin for biofilm penetration • Fluoroquinolones for skeletal distribution • Daptomycin for high bioavailability • Treatment individualized by pathogen/patient **🔧 SURGICAL TREATMENT OPTIONS:**[web:223][web:231] **1. DAIR (Debridement, Antibiotics, Implant Retention):** • High success rates in infected UKA[web:226] • Best for early acute PJI • Requires biofilm-active antibiotics • Timing critical for success **2. Two-Stage Revision (GOLD STANDARD):**[web:231] • Standard for serious chronic PJI • Stage 1: Component removal + antibiotic spacer • Mobile vs static spacer options • Cement + soft tissue debridement • Stage 2: Reimplantation after infection control **3. One-Stage Revision:** • Selected patients • Known organism with antibiotic sensitivity • Adequate soft tissue coverage • Lower morbidity vs two-stage **4. Salvage Procedures:**

🦴 **2025 TREATMENT CONTROVERSIES: Proximal Humerus Fractures** Evidence-based management with surgical video demonstrations and imaging 📊 **KEY 2025 PHF EVIDENCE:**[web:204] **Epidemiology:** • Account for 5-6% of all adult fractures • Peak incidence: Age >80 years • 70% occur in patients >60 years • Increasing recognition in osteoporotic/fragility fractures • Growing global impact on healthcare costs **Treatment Algorithm 2025:**[web:204][web:210] **Non-Operative Management:** • Sling immobilization + progressive rehabilitation • Indicated for: Minimally displaced fractures • Acceptable for: Selected two-part fractures • Crucial for: Patients with severe comorbidities • Dependent patients: Non-operative is appropriate **Surgical Options:** 1. **Open Reduction Internal Fixation (ORIF):**[web:204] • Most common surgical treatment • Locking plate fixation preferred • Critical: Anatomic restoration of head-tuberosity-shaft • Younger patients with displaced fractures • Two- or three-part fractures 2. **Hemiarthroplasty (HA):**[web:206] • Displaced 3-4 part fractures • Anatomic head displacement • Head-split fractures • Requires intact/repairable tuberosities • Allows early return to motion 3. **Reverse Total Shoulder Arthroplasty (rTSA):**[web:204][web:206] • **PREFERRED treatment for elderly patients** • Unreconstructible fractures • Not dependent on tuberosity healing • Not dependent on rotator cuff function • Better outcomes vs hemiarthroplasty • Tuberosity healing improves rotation **❗ CRITICAL SURGICAL CONSIDERATIONS:**[web:204] **Tuberosity Management:** • Proper tuberosity healing VITAL for outcomes • Failed healing in HA = devastating functional loss • Failed healing in rTSA = reduced rotation but maintained elevation • Anatomic tuberosity positioning essential **Age-Based Approach:** • Younger patients: Prioritize fixation techniques • Middle-aged: HA if fixation not feasible • Elderly: rTSA increasingly preferred **📉 RECENT EVIDENCE 2025:**[web:212]